These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 7087714)

  • 21. Isosorbide dinitrate.
    Vaida A
    Minn Med; 1983 Jan; 66(1):41-2. PubMed ID: 6843537
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of trekrezan on the lipid peroxidation in patients with chronic cardiac insufficiency].
    Sabadyshin RO; Slipak OIa; Koval'chuk SF; D'iakov VM; Kazimirovskaia VB
    Biull Eksp Biol Med; 1998 Aug; 126(8):186-8. PubMed ID: 9777233
    [No Abstract]   [Full Text] [Related]  

  • 23. Ranolazine, a novel anti-anginal agent, does not alter isosorbide dinitrate- or sildenafil-induced changes in blood pressure in conscious dogs.
    Zhao G; Messina E; Xu X; Ochoa M; Serpillon S; Shryock J; Belardinelli L; Hintze TH
    Eur J Pharmacol; 2006 Jul; 541(3):171-6. PubMed ID: 16777088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Electron microscopic observations of the ciliary epithelium of rabbit after chronic topical administration of 1% bupranolol (author's transl)].
    Araki M; Ogata T
    Nippon Ganka Gakkai Zasshi; 1980 Oct; 84(10):1731-7. PubMed ID: 7257991
    [No Abstract]   [Full Text] [Related]  

  • 25. Dilating effects of isosorbide dinitrate on diameter of internal thoracic artery graft.
    Koike R; Kimura H
    J Thorac Cardiovasc Surg; 1993 Jun; 105(6):1121-2. PubMed ID: 8501944
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chronic aortic and mitral valve regurgitation. Effects of isosorbide dinitrate on systolic function and passive elastic properties of the left ventricle (author's transl)].
    Herreman F; Cosma H; Degeorges M
    Nouv Presse Med; 1982 Jun; 11(27):2095-100. PubMed ID: 7110972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant labeling and dosing changes for isosorbide dinitrate.
    Drown DJ
    Prog Cardiovasc Nurs; 1997; 12(4):32-3. PubMed ID: 9433732
    [No Abstract]   [Full Text] [Related]  

  • 28. [Coronary artery dilatation induced by isosorbide dinitrate injection (author's transl)].
    Lablanche JM; Delforge MR; Timant PY; Thieuleux FA; Bertrand ME
    Nouv Presse Med; 1982 Jun; 11(27):2057-61. PubMed ID: 7110965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
    Aronow S
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ITF 296, a new endothelium-independent vasodilator: comparison with nitroglycerin and isosorbide dinitrate.
    Ghaleh B; Dubois-Randé JL; Hittinger L; Berdeaux A; Giudicelli JF
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S6-12. PubMed ID: 8839220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma levels of isosorbide dinitrate and the isosorbide mononitrates after increasing doses of a retard preparation of isosorbide dinitrate.
    Bogaert MG; Rosseel MT
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2424-7. PubMed ID: 7422532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Results obtained with a drug combination used in chronic bronchopulmonary diseases].
    Vives CF; Pastor CA
    Prensa Med Argent; 1972 May; 59(14):552-7. PubMed ID: 5042135
    [No Abstract]   [Full Text] [Related]  

  • 34. [Early diagnosis and early treatment of chronic bronchial diseases for the prevention of early invalidity].
    Wilde W
    Z Allgemeinmed; 1975 Nov; 51(31):1438-9. PubMed ID: 1199180
    [No Abstract]   [Full Text] [Related]  

  • 35. [Results of continous therapy with atrovent in diurnal and long-term administration].
    Reichel G
    Wien Med Wochenschr Suppl; 1974 Dec; 21():26-9. PubMed ID: 4531774
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mucoactive therapy in pulmonological practice: current aspects].
    Shmeleva NM; Shmelev EI
    Ter Arkh; 2013; 85(3):107-9. PubMed ID: 23720854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On the use of yeasts in chronic bronchial inflammations].
    Rosica V; Giannini E; Curcio CG
    Clin Ter; 1965 Jul; 34(1):42-6. PubMed ID: 5840762
    [No Abstract]   [Full Text] [Related]  

  • 38. [The respiro-phonogram for the analysis of the effect of a broncho-secretolytic agent].
    Algan O; Kienle H
    Med Monatsschr; 1966 Apr; 20(4):174-8. PubMed ID: 5966185
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of bupranolol in combination with isosorbide dinitrate in bronchial diseases].
    Buchegger G; Vankov T
    Med Welt; 1982 Mar; 33(10):376-8. PubMed ID: 7087714
    [No Abstract]   [Full Text] [Related]  

  • 40. [Isosorbide dinitrate and bupranolol in the therapy of coronary heart disease (author's transl)].
    Pascal N; Eggert R
    Arzneimittelforschung; 1978; 28(5):847-50. PubMed ID: 373775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.